Amazon Quietly Backs Right-Wing Lobbying Group Targeting Tech Antitrust Legislation: Report
Amazon.com Inc. (NASDAQ: AMZN) has poured more than $1 million into a lobbying effort seeking to block the passage of antitrust legislation aimed at major U.S. technology companies.
‘New York Marijuana Regulators Approve Rules To Start Accepting Retailer Applications From People Harmed By Drug War’ -Marijuana Report
https://www.marijuanamoment.net/new-york-marijuana-regulators-approve-rules-to-start-accepting-retailer-applications-from-people-harmed-by-drug-war/
Abercrombie Launches Kids Denim Collection With Sizing Options
Abercrombie & Fitch Co (NYSE:ANF) division, abercrombie kids, has launched its 2022 denim collection, with options for fit and sizing. Additionally,…
Disney+ Signs Deal With Korean Pop Band BTS In An Effort To Boost International Growth
A new deal signed by Walt Disney Co. (NYSE: DIS) might be “smooth like butter” and may provide a boost to the entertainment giant's streaming platform.
JPMorgan Chase and Morgan Stanley Report Earnings: Where Did The Profits Go?
Two of the nation's largest banks, JPMorgan Chase & Co (NYSE: JPM) and Morgan Stanley (NYSE: MS), reported quarterly earnings Thursday that failed to meet analyst expectations, and more seriously, profits were dow
Cintas Q4 Earnings Top Estimates
Cintas Corp (NASDAQ:CTAS) reported fourth-quarter FY22 sales growth of 13% year-on-year to $2.07 billion, beating the consensus of $2.01 billion. The…
Summit Therapeutics Mulls Additional Trial For Its Once Failed Infection Candidate
Summit Therapeutics Inc (NASDAQ:SMMT) provided an update on the clinical development of ridinilazole, its lead Phase 3 product candidate for Clostridioides…
U.S. FDA Defers Decision On BeiGene’s Filing For Esophageal Carcinoma Due To Pending Inspection
The U.S. Food and Drug Administration (FDA) has deferred decision on the Biologics License Application (BLA) for BeiGene’s (NASDAQ: BGNE) tislelizumab as a second-line treatment for patients with unresectable or metastatic esophageal squamous cell carcinoma (ESCC).